New Polycythemia Findings from Hospital Clinic Published (Follow-up of a Cohort of Patients with Secondary Erythrocytosis Due to Testosterone Treatment).

A study conducted at Hospital Clinic in Barcelona, Spain, focused on patients with polycythemia secondary to testosterone treatment. The research found that erythropoietin does not play a role in the mechanism of action for testosterone-induced polycythemia. Patients in the study had a high rate of thrombotic events, emphasizing the importance of maintaining a good hematocrit level and effectively treating comorbidities. The study included 512 patients diagnosed with polycythemia, with 29 patients (5.6%) having polycythemia secondary to testosterone therapy. [Extracted from the article]

Copyright of Cardiovascular Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)